Company intelligence / Profile preview

US BioDesign

Ownership: Private
Development stage: Commercial

Overview

US BioDesign developed and supplied custom-engineered biomedical textiles and structures for integration into commercial medical devices, primarily in cardiovascular, neurovascular, general surgery, orthopedic, and neurological markets. Focus on rapid prototyping and OEM solutions for medical device companies. No evidence of internally developed drugs or biologics; company acted as a supplier/partner to device developers.

Therapeutic areas: CardiovascularNeurologyOther
Modalities: Device
Industry: Chemicals & Materials

Beyond the preview

Go deeper on US BioDesign.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on US BioDesign.

Explore the full profile